Cost-effectiveness of lenacapavir for PrEP in Africa

By sjmartinez • September 24, 2024

Davey DJ, Jamieson L. Cost-effectiveness of lenacapavir for PrEP in Africa. Lancet HIV. 2024 Sep 20:S2352-3018(24)00242-X. doi: 10.1016/S2352-3018(24)00242-X. Epub ahead of print. PMID: 39312934.

Tags: Infectious Diseases, Publications

Libraries Burned, a Life Lived

Vijayan T. Libraries Burned, a Life Lived. N Engl J Med. 2025 Jul 5. doi: 10.1056/NEJMp2500746. Epub ahead of print. PMID: 40621845.

Epidemiology and phylogenomic characterisation of two distinct mpox outbreaks in Kinshasa, DR Congo, involving a new subclade Ia lineage: a retrospective, observational study

Wawina-Bokalanga T, Merritt S, Kinganda-Lusamaki E, Jansen D, Halbrook M, O'Toole Á, Pukuta-Simbu E, Hasivirwe Vakaniaki E, Ola-Mpumbe R, Kwete-Mbokama P, Akil-Bandali P, Kacita C,[...]

Stakeholder priorities for ART initiation and early retention strategies in Malawi: a qualitative study comparing international and national perspectives

Hariprasad S, Phiri K, Thorp M, Holland K, Nyirenda R, Gupta S, Phiri S, Sabin LL, Dovel K. Stakeholder priorities for ART initiation and early[...]